SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000849146-21-000031
Filing Date
2021-02-02
Accepted
2021-02-02 16:07:04
Documents
49
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 10-Q lfvn-20201231.htm   iXBRL 10-Q 1133000
2 EX-31.1 lfvn_123120xex311.htm EX-31.1 9765
3 EX-31.2 lfvn_123120xex312.htm EX-31.2 9751
4 EX-32.1 lfvn_123120xex321.htm EX-32.1 5071
5 EX-32.2 lfvn_123120xex322.htm EX-32.2 5057
  Complete submission text file 0000849146-21-000031.txt   4682611

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lfvn-20201231.xsd EX-101.SCH 26118
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT lfvn-20201231_cal.xml EX-101.CAL 65292
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lfvn-20201231_def.xml EX-101.DEF 113052
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lfvn-20201231_lab.xml EX-101.LAB 421176
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lfvn-20201231_pre.xml EX-101.PRE 245631
11 EXTRACTED XBRL INSTANCE DOCUMENT lfvn-20201231_htm.xml XML 671718
Mailing Address 3300 TRIUMPH BLVD SUITE 700 LEHI UT 84043
Business Address 3300 TRIUMPH BLVD SUITE 700 LEHI UT 84043 801-432-9000
Lifevantage Corp (Filer) CIK: 0000849146 (see all company filings)

IRS No.: 841097796 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-35647 | Film No.: 21581463
SIC: 2834 Pharmaceutical Preparations